PI3K/Akt/mTOR pathway activation caused by PTEN downregulation in the pathogenesis of CD

被引:0
|
作者
He, Yao
Long, Shunhua
Chen, Minhu
Cao, Kang
Chen, Yujun
Chen, Baili
Mao, Ren
Zhang, Shenghong
Zeng, Zhirong
Hu, Pinjin
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
关键词
Crohn's disease; PI3K/Akt/mTOR; PTEN; pathogenesis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:362 / 362
页数:1
相关论文
共 50 条
  • [31] ACTIVATION OF RENAL PI3K/Akt/mTOR SIGNALING PATHWAY IN OBSTRUCTIVE UROPATHY IN RATS
    Ma, Seong Kwon
    Joo, Soo Yeon
    Kim, Chang Seong
    Choi, Joon Seok
    Bae, Eun Hui
    Lee, JongUn
    Kim, Soo Wan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 109 - 109
  • [32] Frequent Aberrant Activation of the PI3K/Akt/mTOR Pathway in Pancreatic Endocrine Tumors
    Zhou, X. P.
    Frankel, W. L.
    Bloomston, M.
    Iwenofu, O. H.
    Bellizzi, A. M.
    MODERN PATHOLOGY, 2009, 22 : 327A - 327A
  • [33] Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
    Dong, Chao
    Wu, Jiao
    Chen, Yin
    Nie, Jianyun
    Chen, Ceshi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
  • [35] Downregulation of Serum PTEN Expression in MercuryExposed Population and PI3K/AKT Pathway-Induced Inflammation
    Mei, Peng
    Ding, En Min
    Yin, Hao Yang
    Ding, Xue Xue
    Wang, Huan
    Wang, Jian Feng
    Han, Lei
    Zhang, Heng Dong
    Zhu, Bao Li
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2024, 37 (04) : 354 - 366
  • [36] PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)
    Miricescu, Daniela
    Balan, Daniela Gabriela
    Tulin, Adrian
    Stiru, Ovidiu
    Vacaroiu, Ileana Adela
    Mihai, Doina Andrada
    Popa, Cristian Constantin
    Papacocea, Raluca Ioana
    Enyedi, Mihaly
    Sorin, Nedelea Andrei
    Vatachki, Guenadiy
    Georgescu, Dragos Eugen
    Nica, Adriana Elena
    Stefani, Constantin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (05)
  • [37] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
    Barra, Fabio
    Desideri, Lorenzo Ferro
    Ferrero, Simone
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3626 - 3627
  • [38] Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
    LoRusso, Patricia Mucci
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3803 - +
  • [39] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 335 - 342
  • [40] Evaluation of the PI3K/AKT/mTOR pathway in multiple sclerosis
    Mammana, Santa
    Fagone, Paolo
    Cavalli, Eugenio
    Basile, Maria Sofia
    Petralia, Maria Cristina
    Nicoletti, Ferdinando
    Mangano, Katia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S51 - S51